Skip to main content
Karo Pharma AB logo

Karo Pharma AB — Investor Relations & Filings

Ticker · KARO ISIN · SE0007464888 LEI · 213800G54Z51LOPGTA79 ST Manufacturing
Filings indexed 653 across all filing types
Latest filing 2015-10-28 M&A Activity
Country SE Sweden
Listing ST KARO

About Karo Pharma AB

https://www.karohealthcare.com/

Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.

Recent filings

Filing Released Lang Actions
KARO BIO ACQUIRES OVER 90 PER CENT OF MEDCORE
M&A Activity Classification · 98% confidence The document is a press release dated October 28, 2015, announcing that Karo Bio has acquired over 90% of the shares in MedCore AB. This transaction involves the purchase of shares and a corresponding share issue to finance the acquisition. This clearly falls under the category of corporate actions related to mergers, acquisitions, or takeover bids. Reviewing the definitions: - 10-K, AR, IR: Not a full financial report. - ER: Not an earnings release. - CAP: While it involves shares, the primary event is the acquisition itself, not general financing. - TAR (M&A Activity): Defined as 'Announcements and documents related to merger proposals or takeover bids.' This acquisition announcement fits this description perfectly. Therefore, the most appropriate classification is M&A Activity (TAR). The document length is short (1744 chars), but it is the primary announcement of the transaction, not just a notice that a report is attached, so RPA/RNS is less specific than TAR.
2015-10-28 English
KARO BIO FÖRVÄRVAR MER ÄN 90 PROCENT AV AKTIERNA I MEDCORE
M&A Activity Classification · 98% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and dated October 28, 2015. The content explicitly details the acquisition of over 90% of the shares in MedCore AB by Karo Bio AB for 18 MSEK, paid partly with newly issued shares. This transaction involves a merger/takeover activity (acquisition of another company). Based on the definitions, the most appropriate category for an announcement regarding a merger proposal or takeover bid is 'M&A Activity' (Code: TAR). The document is a formal announcement of a significant corporate transaction, not a general regulatory filing (RNS) or a report itself.
2015-10-28 Swedish
KARO BIO ACQUIRES SWERECO GROUP.
M&A Activity Classification · 95% confidence The document is a short press release dated October 2, 2015, announcing a specific corporate action: the acquisition of Swereco Group by Karo Bio AB. This is a material event announcement concerning corporate structure/strategy, not a routine financial report (like 10-K, IR, ER) or a general regulatory filing. Since the definitions do not explicitly cover M&A announcements, I must evaluate the closest fit. The M&A Activity (TAR) definition covers 'merger proposals or takeover bids.' An acquisition announcement fits this category best as it details a significant transaction impacting the company's structure and future operations. The document is short and serves as an immediate announcement, not a detailed regulatory filing.
2015-10-02 English
KARO BIO KÖPER SWERECO GROUP
M&A Activity Classification · 95% confidence The document is titled "PRESSMEDDELANDE" (Press Release) and dated October 2, 2015. The content details a significant corporate action: Karo Bio AB acquiring Swereco Group for 250 MSEK, paid partly in cash and partly through newly issued shares. This constitutes a major corporate transaction involving financing/capital structure changes related to the acquisition. This fits best under Capital/Financing Update (CAP), as it explicitly details the purchase price and the method of payment (cash + new shares). While it is an M&A announcement, the focus on the financing structure makes CAP highly relevant, but since M&A activity (TAR) is defined as merger proposals or takeover bids, and this is a completed acquisition announcement detailing the capital structure change for the purchase, TAR is the primary fit for the M&A event itself. However, the description for CAP is 'Updates on company fundraising, financing activities, or capital structure changes.' Since the core of the announcement is the acquisition and how it is being financed (new shares issued), TAR (M&A Activity) is the most specific category for the event described, which is a takeover/acquisition. Given the options, TAR is the most appropriate classification for an acquisition announcement.
2015-10-02 Swedish
Declaration of Voting Results & Voting Rights Announcements 2015
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document details a change in shareholding for an individual, Anders Lönner, associated with Karo Healthcare AB. It explicitly shows the 'Before the transaction' and 'After the transaction' share counts and voting rights percentages. The section 'Reason for major shareholding notification Option exercise' confirms the nature of the filing. This structure perfectly matches the definition of a Major Shareholding Notification, which is classified as 'MRQ' in the provided schema.
2015-09-04 English
KARO BIO FÖRVÄRVAR APROPHARM
M&A Activity Classification · 98% confidence The document is a press release dated September 1, 2015, announcing that Karo Bio AB is acquiring Apropharm AS and Apropharm AB. This announcement details a significant corporate transaction involving the purchase of another company and its product portfolio. This falls under the category of Mergers & Acquisitions (M&A) activity. The corresponding code is TAR (M&A Activity). The document is short and is an announcement of a transaction, not a comprehensive financial report.
2015-09-01 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.